Medicinova Headquarters
Looking for information about Medicinova Headquarters? The links below have collected all the necessary data.
Contact Us - MediciNova, Inc.
- https://medicinova.com/contact-us/
- MediciNova, Inc. Corporate Address 4275 Executive Square, Suite 300 La Jolla, CA 92037 USA. If you are a patient, a family member of a patient, a physician, an investigator, or any other person with a question or concern about any of our clinical trials, clinical development programs or plans for the future, please do not call the company.
Home - MediciNova, Inc.
- https://medicinova.com/
- Home - MediciNova, Inc. MediciNova. is a. biopharmaceutical company. that is developing. novel therapeutics. with a primary focus on. neurology, respiratory, and …
Company - MediciNova, Inc.
- https://medicinova.com/company/
- Company. MediciNova, Inc. is a publicly-traded biopharmaceutical company focused on acquiring and developing novel, small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Through strategic alliances primarily with Japanese pharmaceutical companies, MediciNova holds rights to ...
MediciNova Company Profile - Office Locations, Competitors ...
- https://craft.co/medicinova
- Jun 29, 2021 · MediciNova headquarters is located at 4275 Executive Square #650, La Jolla, San Diego. Where are MediciNova offices? MediciNova has an office in San Diego. How many offices does MediciNova have? MediciNova has 2 offices. Learn about Craft real-time company insights.Employees: 8
MediciNova - Crunchbase Company Profile & Funding
- https://www.crunchbase.com/organization/medicinova
- MediciNova is a biopharmaceutical company focused on acquiring and developing novel, small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Through strategic alliances primarily with Japanese pharmaceutical companies, MediciNova holds rights to a diversified portfolio ofFounded: 2000
MediciNova History - MediciNova, Inc.
- https://medicinova.com/company/medicinova-history/
- MediciNova History. MediciNova, Inc. was founded in September 2000 with $10 million in Series A seed funding from Tanabe Seiyaku Co., Ltd. (Osaka). MediciNova was established in San Diego as a biopharmaceutical company focused on acquiring and accelerating the global development and commercialization of innovative pharmaceutical products.
MediciNova Company Profile: Stock Performance & Earnings ...
- https://pitchbook.com/profiles/company/40460-68
- MediciNova General Information Description. MediciNova Inc is a biopharmaceutical company. It acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc.
Corporate Governance MediciNova, Inc.
- https://investors.medicinova.com/corporate-governance/highlights/
- MediciNova, Inc. is committed to sound principles of corporate governance and is managed under the direction of its Board of Directors. Provided below is information concerning the charters that guide our Board committees, our code of business conduct and code of ethics, and other important corporate governance documents.
MediciNova Announces Kick-off Meeting to Officially Launch ...
- https://investors.medicinova.com/news-releases/news-release-details/medicinova-announces-kick-meeting-officially-launch-phase-3
- Jun 05, 2019 · LA JOLLA, Calif., June 05, 2019 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq: MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that a kick-off meeting for the Phase 2b/3 clinical trial of MN-166 (ibudilast) in amyotrophic lateral sclerosis (ALS) was held on June 5, 2019 at MediciNova ...
Presentations - MediciNova, Inc.
- https://medicinova.com/presentations/
- MN-001 (tipelukast) Presentations and Publications. MN-001 for Fibrotic Diseases. Liver Fibrosis (NASH or others) Pulmonary Fibrosis (IPF) Learn More. MN-166 …
Have you found Medicinova Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.